Chapter 1 Substances of Abuse and Hallucinogenic Activity: The Dopaminergic Pathway - Focus on Cocaine and Amphetamine-type Stimulants

Chapter 2 Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens

Chapter 3 Substances of Abuse and Hallucinogenic Activity: The Glutamatergic Pathway - Focus on Ketamine

Chapter 4 Chronic Hallucinatory Disorder “an Equivalent” of Delusional Disorder

Chapter 5 Hallucinations in the Substance-Induced Psychosis

Chapter 6 Hallucinatory Symptomatology in Major Psychoses (Schizophrenia and Bipolar Disorders)

Chapter 7 Hallucinations in Neurological Disorders

Chapter 9 Imaging Genetics of Hallucinations

Chapter 10 Dysconnectivity in Hallucinations

Chapter 11 Translating Neurocognitive Models of Auditory Verbal Hallucinations in Schizophrenia into Novel Therapeutic Interventions

Chapter 12 Innovative Approaches to Hallucinations in Psychosis and Affective Disorders: A Focus on Noninvasive Brain Stimulation Interventions